Repros Therapeutics Inc. (Nasdaq: RPRX) noted that it will participate as a sponsor in a forthcoming public advisory committee meeting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE